Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
CC transcript
Director departure
Appointed director

VOLITIONRX LTD (VNRX) Create: Alert

All | News | Filings
Date FiledTypeDescription
05/16/2017 8-K Form 8-K - Current report
03/16/2017 8-K Form 8-K - Current report
11/15/2016 8-K Form 8-K - Current report
08/16/2016 8-K Quarterly results, Conference call transcript
Docs: "VolitionRx Announces Second Quarter 2016 Financial Results and Business Update",
"Transcript of Conference Call held on August 11, 2016"
05/19/2016 8-K Quarterly results, Conference call transcript
Docs: "VolitionRx Announces First Quarter 2016 Financial Results and Business Update Namur, Belgium, May 13, 2016 - VolitionRx Limited , a life sciences company focused on developing blood-based diagnostic tests for a broad range of cancer types and other conditions, today announced financial results for the first quarter ended March 31, 2016. First Quarter 2016 and Recent Company Highlights:",
"Transcript of Conference Call held on May 13, 2016"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy